The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Gilead (GILD): 'A stock for all seasons'

 Sep 25, 2009 06:00 PM UTC
Return Risk
+5.21% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
GILD Positive 09/25/09 -1.91% 10/12/09

Graphic_arrow1 Via BloggingStocks:  

Filed under: Newsletters, Gilead Sciences (GILD), Stocks to Buy

"Gilead Sciences (NASDAQ: GILD), one of the world's largest biotechs, is a stock for all seasons," say growth expert Alexander Green.


The investment director for The Oxford Club explains, "It's a fine company with a solid balance sheet, a recession-proof business and excellent growth prospects."


"Gilead focuses on three main areas, including cardiovascular conditions and respiratory diseases. (Many may have taken its anti-influenza drug Tamiflu, Letairis to treat hypertension, or Macugen to treat macular degeneration.)

Continue reading Gilead (GILD): 'A stock for all seasons'

Gilead (GILD): 'A stock for all seasons' originally appeared on BloggingStocks on Fri, 25 Sep 2009 13:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati




 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch